CAMP Phosphodiesterase: A Key Enzyme in Intracellular Signaling

Target Name: cAMP Phosphodiesterase

NCBI ID: P10815

cAMP Phosphodiesterase

Other Name(s): PDE

CAMP Phosphodiesterase: A Key Enzyme in Intracellular Signaling

CAMP phosphodiesterase (PDE), a nonspecific subtype of the PDE family, is a critical enzyme involved in intracellular signaling. It catalyzes the breakdown of cAMP, a key signaling molecule that plays a vital role in various physiological processes, including cell signaling, ion channels , and gene expression. Its function is highly conserved across various species, and its structure and mechanism of action have been well-studied.

The CAMP phosphodiesterase enzyme is a key enzyme in the cAMP signaling pathway, which is a complex network of enzymes that regulate various cellular processes. The cAMP signaling pathway is involved in a wide range of physiological processes, including cell signaling, cell growth, cell differentiation , and intracellular signaling. It is activated by various signaling molecules, including protein kinases, hormones, and neurotransmitters.

The CAMP phosphodiesterase enzyme is a key enzyme in the cAMP signaling pathway, as it catalyzes the breakdown of cAMP, which is the primary target of the signaling molecule. The breakdown of cAMP by CAMP phosphodiesterase creates a second messenger adenosine (A2), which can then be converted to its active form, adenosine monophosphate (AMP), by the addition of a phosphate group. AMP is a powerful signaling molecule that can activate various cellular processes, including protein kinases, transcription factors, and ion channels.

The CAMP phosphodiesterase enzyme has a highly conserved structure and mechanism of action. It has a catalytic active site, which is the site of the reaction between the substrate and the enzyme. The active site is located at the base of the catalytic loop and consists of a Rossmann-fold, a deep cleft, and a side chain. The Rossmann-fold is a key structural feature that binds the substrate, while the deep cleft and side chain provide the basic stability of the enzyme.

The CAMP phosphodiesterase enzyme has a unique mechanism of action. It is a Michaelis-Menten enzyme, which means that the rate of the reaction is limited by the availability of the substrate. Michaelis-Menten kinetics are a model that describes the binding of an enzyme to its substrate and the rate of the reaction. The Michaelis constant (Km) is a critical parameter that describes the affinity of the substrate for the enzyme.

The CAMP phosphodiesterase enzyme has a wide range of substrates, including nucleotides, proteins, and small molecules. Its substrate specificity is highly regulated, and it can selectively interact with certain substrates. The substrate regulation specificity is an important aspect of the enzyme's mechanism of action, and it plays a vital role in the specificity of various cellular processes.

The CAMP phosphodiesterase enzyme is a potential drug target and biomarker. Its function in intracellular signaling and its unique mechanism of action make it an attractive target for small molecule inhibitors. The development of inhibitors for the CAMP phosphodiesterase enzyme has the potential to treat a wide range of diseases, including neurodegenerative disorders, cardiovascular diseases, and diseases associated with inflammation.

In conclusion, the CAMP phosphodiesterase (PDE) is a critical enzyme involved in intracellular signaling. Its unique structure and mechanism of action make it an attractive target for small molecule inhibitors. Further research is needed to develop inhibitors for the CAMP phosphodiesterase enzyme and to understand its role in various cellular processes.

Protein Name: CAMP Phosphodiesterase (nonspecified Subtype)

The "cAMP Phosphodiesterase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about cAMP Phosphodiesterase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets